GO	[-8.26 -0.63]	[-0.63 -0.36]	[-0.36 -0.21]	[-0.21 -0.09]	[-0.09 0.00]	[0.00 0.02]	[0.02 0.14]	[0.14 0.29]	[0.29 0.52]	[0.52 1.01]	[1.01 7.81]
HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_UP HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_UP	-0.270	-1.259	-2.031	-2.031	-0.782	21.343	-2.031	-2.031	-0.471	-0.471	-0.273
FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN	-0.647	-3.783	-2.259	-1.270	-1.553	-2.695	-1.880	1.010	0.835	5.275	9.541
ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_NEGATIVE ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_NEGATIVE	1.824	-2.299	-2.299	-3.034	-0.962	10.962	-0.962	-1.740	-1.304	0.399	2.152
ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GT_200_VS_LTE_200_1DY_DN ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GT_200_VS_LTE_200_1DY_DN	0.723	-1.595	-0.909	-3.451	-2.072	0.544	-2.072	-0.668	-1.214	3.558	9.527
HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP	2.124	6.483	2.124	0.561	-1.332	-2.821	-0.389	-1.332	-0.910	-1.927	-2.831
FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_UP FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_UP	1.942	-2.132	-2.672	-1.689	-0.778	-0.580	-0.778	-0.580	-0.580	5.042	3.701
THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP	-2.079	0.961	1.152	3.344	0.499	-2.500	2.106	0.788	-0.318	-3.555	-3.005
NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_DN NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_DN	0.878	-0.977	-2.322	-2.322	-0.622	4.002	-2.322	-0.381	0.398	0.398	2.399
FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_UP FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_UP	-0.645	-1.536	-0.398	-1.006	-1.536	-1.536	-0.398	0.588	0.846	0.846	5.782
HARALAMBIEVA_PBMC_M_M_R_II_AGE_13_16YO_STIMULATED_VS_UNSTIMULATED_3_TO_7YR_POST_TOP_DEG_UP HARALAMBIEVA_PBMC_M_M_R_II_AGE_13_16YO_STIMULATED_VS_UNSTIMULATED_3_TO_7YR_POST_TOP_DEG_UP	1.931	-1.024	-1.741	-0.599	-0.599	-0.599	-0.599	-1.024	0.750	-0.336	4.932
HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_UP HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_UP	-0.538	0.477	-0.176	-0.538	-0.538	6.678	-0.538	-0.538	-0.538	-0.176	-0.540
QI_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_ZOSTAVAX_AGE_52_75YO_CD4_T_CELL_VS_NAIVE_CD4_T_CELL_7_TO_9DY_DN QI_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_ZOSTAVAX_AGE_52_75YO_CD4_T_CELL_VS_NAIVE_CD4_T_CELL_7_TO_9DY_DN	-0.373	-0.373	-0.373	-0.373	-0.373	7.423	-0.373	-0.373	-0.373	-0.373	0.239
ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN	-2.549	-0.691	0.616	1.084	0.435	-1.869	1.370	1.689	0.833	-0.473	-1.878
QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_0DY_UP QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_0DY_UP	0.279	-0.787	-0.787	-0.787	0.609	0.279	-0.787	-0.324	-0.787	0.279	4.775
HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_DN HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_DN	0.985	0.381	-1.492	-0.828	0.647	1.391	-0.828	-0.828	-1.492	-0.453	2.383
GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_DN GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_DN	-1.728	-0.947	-1.169	-0.263	1.914	-0.352	4.836	0.343	-0.947	-0.263	-0.604
FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_14DY_POSITIVE FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_14DY_POSITIVE	0.727	1.150	0.727	-1.035	-1.035	-1.035	-1.035	0.398	0.727	1.150	-1.039
OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP	-1.733	0.349	1.178	1.178	-0.360	-1.385	1.410	1.410	-0.652	0.349	-2.655
LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN	0.762	-0.662	-0.247	-0.662	-0.247	2.698	-0.662	-0.662	-0.247	-0.662	1.288
HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_DN HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_DN	-0.538	-0.176	-0.176	-0.538	-0.538	1.604	-0.538	-0.538	-0.538	0.968	1.599
FISCHER_BLOOD_PLASMA_RVSV_EBOV_AGE_18_55YO_HIGH_DOSE_3DY_DN FISCHER_BLOOD_PLASMA_RVSV_EBOV_AGE_18_55YO_HIGH_DOSE_3DY_DN	-0.248	-0.248	-0.248	-0.248	-0.248	4.467	-0.248	-0.248	-0.248	0.361	-0.249
QI_NAIVE_T_CELL_ZOSTAVAX_AGE_52_75YO_CD4_T_CELL_VS_NAIVE_CD4_T_CELL_7_TO_9DY_UP QI_NAIVE_T_CELL_ZOSTAVAX_AGE_52_75YO_CD4_T_CELL_VS_NAIVE_CD4_T_CELL_7_TO_9DY_UP	-0.248	-0.248	-0.248	-0.248	-0.248	4.467	0.361	-0.248	-0.248	-0.248	-0.249
